Clinical Trials in San Francisco

Showing 7561-7580 of 12,991 trials

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

NCT01425008

This is a phase 1, multicenter, nonrandomized, open-label, dose escalation study. The study will be conducted in 2 stages, Dose Escalation and Dose Expansion. The Dose Escalation phase will include participants with solid tumors (including melanoma) who have failed or are not candidates for standard therapies or for whom no approved therapy is available. The Dose Expansion phase will include participants with metastatic melanoma.

MelanomaMetastatic MelanomaSolid Tumor+1 more

Millennium Pharmaceuticals, Inc.149 participantsStarted Sep 2011

San Francisco, California, United States • Denver, Colorado, United States • Augusta, Georgia, United States +13 more locations

COMPLETEDNA< 1 mile

Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders

NCT02936401

The purpose of this study is to determine the efficacy of Mindfulness Based Stress Reduction (MBSR) to alleviate stress, anxiety, and depressive symptoms, and improve attention among patients aged 60 or older who suffer from HIV-associated neurocognitive disorders (HAND) and have maximized treatment options.

Impaired CognitionHIV Infection

University of California, San Francisco180 participantsStarted Mar 2015

San Francisco, California, United States

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders

Find Trials by Condition in San Francisco

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

Valganciclovir to Reduce T Cell Activation in HIV Infection

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures

Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)

Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients

A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System

Lorcaserin in the Treatment of Cocaine Use Disorder

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach

A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350

Multi-Center Study of New Medications to Treat Vaginal Infections

Enhancing mHealth Technology to Activate Chronic Care Patients

Self-management to Improve Function Following Amputation

Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding